Chest shielding in preterm neonates under phototherapy-a randomised control trial.
Chest shielding
Haemodynamically significant PDA
Phototherapy
Preterm neonates
Journal
European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
23
01
2020
accepted:
30
07
2020
revised:
25
07
2020
pubmed:
20
8
2020
medline:
24
6
2021
entrez:
20
8
2020
Statut:
ppublish
Résumé
Shielding the precordium can effect manifestation of haemodynamically significant patent ductus arteriosus (hsPDA). Preterm neonates born at ≤ 32 weeks of gestation if needed phototherapy within 72 h of birth and had no echocardiographically proven hsPDA were eligible to be enrolled in this open-label randomised controlled trial. In chest shielding group, in addition to the standard care, left side of the chest was covered using food grade aluminium foil during phototherapy while control group received standard care. Mean gestational age (weeks; 30.1 ± 1.5 vs 30.1 ± 1.6) was comparable in the two groups. However, neonates in the chest shield group had lower birth weight (g; 1281 ± 259 vs 1422 ± 307) and were more likely to be small-for-gestational age (21.6% vs 8.0%). It was seen that 4 (7.8%) babies in the chest shield group and 5 (10%) babies in the standard group developed hsPDA after starting phototherapy with relative risk (RR) of 0.78 (95% CI 0.22-2.75). The left atrium to aortic ratio was significantly different in the two groups with 1.5 ± 0.1 in the chest shield group and 1.8 ± 0.2 in standard group (p value 0.03).Conclusion: Chest shielding of preterm babies during phototherapy has no effect on the incidence of haemodynamically significant patent ductus arteriosus.Trial registration: Trial was registered with Clinical trial registry of India (CTRI/2018/01/011069). What is Known: • Chest shielding in preterm neonates under phototherapy has inconclusive effect on the manifestation of patent ductus arteriosus. What is New: • Preterm neonates under phototherapy have no significant difference in manifestation of haemodynamically significant patent ductus arteriosus if precordium is shielded.
Identifiants
pubmed: 32813124
doi: 10.1007/s00431-020-03763-9
pii: 10.1007/s00431-020-03763-9
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
767-773Références
McMurphy DM, Heymann MA, Rudolph AM et al (1972) Development changes in constriction of the ductus arteriosus: response to oxygen and vasoactive agents in the isolated ductus arteriosus of the fetal lamb. Pediatr Res 6:231–238
doi: 10.1203/00006450-197204000-00004
Investigators of the Vermont-Oxford Trials Network Database Project (1993) The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Pediatrics 91:540–545
Heymann MA, Berman W, Rudolph AM et al (1979) Dilatation of the ductus arteriosus by prostaglandin E, in aortic arch abnormalities. Circulation 59:169–173
doi: 10.1161/01.CIR.59.1.169
Bouayad A, Kajino H, Waleh N, Fouron JC, Andelfinger G, Varma DR et al (2001) Characterization of PGE(2) receptors in fetal and newborn lamb ductus arteriosus. Am J Physiol Heart Circ Physiol 280:H 2342–H 2349
doi: 10.1152/ajpheart.2001.280.5.H2342
Redline RW, Wilson-Costello D, Hack M (2002) Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 52:713–719
doi: 10.1203/00006450-200211000-00017
Evans N, Kluckow M (1996) Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child 75:F183–F186
doi: 10.1136/fn.75.3.F183
Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA et al (2018) Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 319(12):1221–1238
doi: 10.1001/jama.2018.1896
Ohlsson A, Shah PS (2015) Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants. In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews [Internet].Chichester,UK:JohnWiley&Sons,Ltd. [cited2017Jan30].Availablefrom: http://doi.wiley.com/10.1002/14651858.CD010061.pub2
Sallmon H, Koehne P, Hansmann G (2016 Mar) Recent advances in the treatment of preterm newborn infants with patent ductus arteriosus. Clin Perinatol 43(1):113–129
doi: 10.1016/j.clp.2015.11.008
Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK (2012) An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol 32:660–664
doi: 10.1038/jp.2012.71
Furchgott RF, Ehrreich SJ, Greenblatt E (1961) The photoactivated relaxation of smooth muscle of rabbit aorta. J Gen Physiol 44:499–519
doi: 10.1085/jgp.44.3.499
Benders MJ, van Bel F, van de Bor M (1998) The effect of phototherapy on cerebral blood flow velocity in preterm infants. Acta Paediatr 87(7):786–791
doi: 10.1111/j.1651-2227.1998.tb01748.x
Benders MJNL, Van Bel F, Van de Bor M (1999) Cardiac output and ductal reopening during phototherapy in preterm infants. Acta Paediatr 88:1014–1019
doi: 10.1111/j.1651-2227.1999.tb00199.x
Bhola K, Foster JP, Osborn DA (2015) Chest shielding for prevention of a haemo-dynamically significant patent ductus arteriosus in preterm infants receiving phototherapy. Cochrane Database Syst Rev 11:CD009816
Rosenfeld W, Sadhev S, Brunot V, Jhaveri R, Zabaleta I, Evans H (1986) Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding. Pediatrics 78(1):10–14
pubmed: 3725477
Travadi J, Simmer K, Ramsay J, Doherty D, Hagan R (2006) Patent ductus arteriosus in extremely preterm infants receiving phototherapy: does shielding the chest make a difference? A randomised, controlled trial. Acta Paediatr 95(11):1418–1423
doi: 10.1080/08035250600771458